Expion360 Inc. — Q2 2022 Form 10-Q
Filing identity: The filing is for Expion360 Inc. (Nasdaq: XPON), not “Expion Energy, Inc.” The quarter and six-month periods ended June 30, 2022; financial statements are unaudited. The company designs, assembles, and distributes lithium iron phosphate batteries and accessories, primarily for RV and marine markets.
Financial performance and position
| Metric | Three months ended June 30 | Six months ended June 30 |
|---|---|---|
| Net sales, 2022 | $2.20 million, up 121.7% year over year | $4.36 million, up 132.0% year over year |
| Gross profit / margin, 2022 | $706,326 / 32.1% (37.9% in 2021) | $1.57 million / 36.0% (34.7% in 2021) |
| Operating loss, 2022 | $2.92 million | $3.25 million |
| Net loss, 2022 | $4.09 million, or $0.62 per share | $4.79 million, or $0.88 per share |
| Operating cash flow, 2022 | Not separately presented for the quarter | $(2.73) million, versus $(0.92) million in 2021 |
Q2 selling, general and administrative expense was $3.62 million, compared with $417,426 a year earlier. The six-month amount was $4.82 million, versus $734,841. Management attributes the rise to growth-related staffing and facilities, IPO preparation costs, and other business-development expenses. Q2 gross margin declined, with management citing higher landing costs; the six-month margin improved, which it attributed primarily to product mix and higher sales volume.
At June 30, cash and cash equivalents were $10.39 million, versus $773,238 at December 31, 2021. Current assets were $15.45 million and current liabilities $1.26 million, yielding working capital of approximately $14.19 million. Total assets were $19.93 million and total liabilities $5.58 million. Long-term debt, net of current portion and discount, was $504,330; shareholder promissory notes were $825,000. Operating lease liabilities totaled $3.45 million. The company reported no material off-balance-sheet arrangements.
Material changes and financing
- The April 1 IPO sold 2,466,750 shares at $7 each, generating $17.27 million gross and $14.77 million net proceeds after $2.49 million of issuance costs. Shares outstanding rose to 6,802,464 at June 30 from 4,300,000 at year-end.
- The company used IPO proceeds to repay $550,000 of working-capital loans and approximately $1.7 million of notes, plus $213,895 of related interest. Management reports approximately $2.46 million in debt principal and accrued interest was repaid, including high-interest debt.
- Net financing cash flow was $12.48 million for the six months, primarily reflecting IPO proceeds, partly offset by debt repayments. Capital expenditures were $138,674 in the period.
- Q2 and first-half net losses included significant non-cash charges: $2.11 million of stock-based compensation and, for the six months, $1.20 million of debt-discount amortization. Management stated that approximately $3.3 million of the six-month net loss was non-cash.
Outlook, commentary, and risks
Management expects cash and operating cash flows, together with IPO proceeds, to cover anticipated working capital, capital expenditures, and debt service for at least 15 months. A liquidity-policy note separately says cash is sufficient for at least 12 months after the financial statements’ issuance; this difference should be reconciled. Management says additional capital may be needed to support expansion and its longer-term plan, and cautions that financing may not be available on acceptable terms.
The company is building U.S. assembly capacity, including a Redmond, Oregon facility, and established an Indiana distribution warehouse. Management anticipated $450,000–$950,000 of 2022 spending to expand production facilities and assembly lines; approximately $390,000 of capital additions were expected in the next 12 months as of June 30. The filing does not provide formal revenue or earnings guidance. The planned in-house assembly expansion and profitability objectives are forward-looking and not assured.
- Supply-chain exposure: China and Hong Kong accounted for approximately 91% of inventory purchases in the first half and 96% in Q2. The company reports a Denmark-based secondary cell source, but foreign sourcing, shipping delays, cost increases, and port disruption remain risks.
- Customer concentration: one customer represented approximately 28% of first-half sales and 35% of June 30 receivables. Two customers represented 31% of Q2 sales combined.
- Continued operating losses and negative operating cash flow, competitive pricing, execution of expansion plans, product quality and liability, and possible future financing needs are material risks. The filing also cites COVID-19 and broader economic uncertainty.
- The company had no material legal proceedings and reported no material subsequent events through August 4, 2022. Management concluded disclosure controls were effective at a reasonable-assurance level.
Investor verification priorities
- Reconcile the stated 12-month and 15-month cash-runway estimates, and assess cash burn against expansion and debt-service needs.
- Track whether sales growth converts to improved gross margins and operating cash flow, particularly given Q2 margin compression and higher landing costs.
- Examine the nature and future recurrence of stock compensation and debt-discount amortization that materially affected reported losses.
- Assess customer concentration, Chinese supplier dependence, and whether the Denmark source can meaningfully mitigate supply disruption.
- Review dilution from IPO shares and outstanding warrants/options: the filing reports 1,717,936 shares reserved for future issuance, subject to applicable terms and exercise.
- Confirm progress, costs, and timing for the Oregon assembly line and whether management’s profitability and liquidity assumptions are being met.